CAS 1870916-87-2

6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide

CAS : 1870916-87-2

Formule : C₂₅H₃₄N₄O₆

Degré de pureté : 97%

Couleur et forme : Solid

Masse moléculaire : 486.5607

Ref: IN-DA01K5S5

Mc-Val-Ala-PAB

CAS : 1870916-87-2

Mc-Val-Ala-PAB

Degré de pureté : 98%

Masse moléculaire : 486.56g/mol

Ref: 54-OR1013720

Mc-​Val-​Ala-​PAB

CAS : 1870916-87-2

Mc-​Val-​Ala-​PAB

Degré de pureté : ≥98%

Masse moléculaire : 486.56g/mol

Ref: 54-BUP11233

Mc-​Val-​Ala-​PAB

CAS : 1870916-87-2

Mc-Val-Ala-PAB, an effective linker, is utilized in antibody-drug-conjugate (ADC).

Formule : C₂₅H₃₄N₄O₆

Degré de pureté : 98.34% - 99.24%

Couleur et forme : Solid

Masse moléculaire : 486.56

Ref: TM-T4289

Mc-​Val-​Ala-​PAB

CAS : 1870916-87-2

Formule : C₂₅H₃₄N₄O₆

Degré de pureté : 97%

Masse moléculaire : 486.569

Ref: 10-F546672

Mc-Val-Ala-PAB

CAS : 1870916-87-2

Mc-Val-Ala-PAB is a peptide-based linker, which is a synthetic compound used in targeted drug delivery systems. This compound originates from chemical synthesis techniques and serves as a critical component in the design of prodrugs, particularly antibody-drug conjugates (ADCs). The mode of action involves its cleavage by specific enzymes, such as cathepsins, which are overexpressed in tumor tissues, triggering the release of the active drug selectively within the cancer cells.

Formule : C₂₅H₃₄N₄O₆

Degré de pureté : Min. 95%

Masse moléculaire : 486.6 g/mol

Ref: 3D-VZC91687